Shopping Cart
- Remove All
- Your shopping cart is currently empty
MPTP (1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine) is a dopamine neurotoxin capable of crossing the blood-brain barrier, often employed to induce models of Parkinson's syndrome. As a precursor to MPP+, MPTP can trigger apoptosis (apoptosis).
Pack Size | Price | Availability | Quantity |
---|---|---|---|
10 mg | Inquiry | 10-14 weeks | |
50 mg | Inquiry | 10-14 weeks |
Description | MPTP (1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine) is a dopamine neurotoxin capable of crossing the blood-brain barrier, often employed to induce models of Parkinson's syndrome. As a precursor to MPP+, MPTP can trigger apoptosis (apoptosis). |
In vitro | 50 mM 4-Phenylpyridine pretreatment reduces the IC50 of MPTP, the concentration required for 50% inhibition of twitch amplitude, from 53 mM to 18 mM in mouse phrenic nerve-diaphragm. Additionally, it decreases the IC50 value of d-tubocurarine from 0.7 mM to 0.3 mM. |
Molecular Weight | 173.254 |
Formula | C12H15N |
Cas No. | 28289-54-5 |
Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.